APA (7th ed.) Citation

Peedicayil, J., & Grayson, D. R. (2025). Vafidemstat: A lysine-specific demethylase 1A inhibitor that shows promise for treating neuropsychiatric disorders. Epigenetics Reports, 3(1), 1. https://doi.org/10.1080/28361512.2025.2552947

Chicago Style (17th ed.) Citation

Peedicayil, Jacob, and Dennis R. Grayson. "Vafidemstat: A Lysine-specific Demethylase 1A Inhibitor That Shows Promise for Treating Neuropsychiatric Disorders." Epigenetics Reports 3, no. 1 (2025): 1. https://doi.org/10.1080/28361512.2025.2552947.

MLA (9th ed.) Citation

Peedicayil, Jacob, and Dennis R. Grayson. "Vafidemstat: A Lysine-specific Demethylase 1A Inhibitor That Shows Promise for Treating Neuropsychiatric Disorders." Epigenetics Reports, vol. 3, no. 1, 2025, p. 1, https://doi.org/10.1080/28361512.2025.2552947.